We’d love your feedback


Renal cell carcinoma: Updates on treatment and management

Your valuable comments help us improve the quality of meetings and we are looking forward to hearing your thoughts. We would appreciate if you could kindly take a few minutes to answer the questions below. Thank you very much.

1. Please rate the overall organisation of the meeting:

ExcellentVery GoodGoodSatisfactoryPoor
Excellent
Very Good
Good
Satisfactory
Poor
ExcellentVery GoodGoodSatisfactoryPoor
Excellent
Very Good
Good
Satisfactory
Poor
ExcellentVery GoodGoodSatisfactoryPoor
Excellent
Very Good
Good
Satisfactory
Poor
ExcellentVery GoodGoodSatisfactoryPoor
Excellent
Very Good
Good
Satisfactory
Poor
ExcellentVery GoodGoodSatisfactoryPoor
Excellent
Very Good
Good
Satisfactory
Poor

2. Please rate the following meeting sessions in terms of content, delivery, and quality of discussion:

a) Presentation and discussion
Understanding the impact of the CM9ER data *

ExcellentVery GoodGoodSatisfactoryPoor
Excellent
Very Good
Good
Satisfactory
Poor

b) Presentation and discussion
Treatment choices in 1L RCC and therapeutic sequencing *

ExcellentVery GoodGoodSatisfactoryPoor
Excellent
Very Good
Good
Satisfactory
Poor

c) Case sharing
How Cabo + Nivo fits into the treatment landscape *

ExcellentVery GoodGoodSatisfactoryPoor
Excellent
Very Good
Good
Satisfactory
Poor

d) Presentation and discussion
Gaps in the data and opportunities for further clinical development *

ExcellentVery GoodGoodSatisfactoryPoor
Excellent
Very Good
Good
Satisfactory
Poor

3. Which topic(s) would you like to see covered in future meetings?

4. Any other comments?